Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Adrenal glands delay the start of winter fur growth in mink.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Early diagnosis and treatment of PCOS in teenagers can help prevent more severe adult PCOS.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Acne in children varies by age and severity, requires a pediatric treatment approach, and may need diagnostic evaluation for underlying conditions.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

A mother and daughter have a rare genetic hair loss disorder with no effective treatment.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.